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Abstract
A number of biological roles have been proposed for
quadruplex, also referred to as G4 or tetraplex, DNA. The
presence of quadruplex DNA may lead to errors in some
biological processes and be required in others. Proteins that
interact with quadruplex DNA have been identified including
those that cause Bloom’s and Werner’s syndromes. There are
small molecules that specifically bind to quadruplex DNA, inhibit
telomerase, and are cytotoxic towards tumor cells indicating a role
for quadruplex DNA in telomere function. It is now possible to
make testable proposals for the possible biological implications of
quadruplex DNA in replication, transcription, and recombination
as well as possible routes to therapeutic intervention. ß 2001
Elsevier Science Ltd. All rights reserved.
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1. Introduction
Quite recently proteins have been found that have high
a⁄nity for quadruplex, also known as G4 or tetrahelical,
DNA and defects in these proteins can lead to errors in
replication, transcription, and recombination as well as to
increases in the rates of aging and tumor formation [1^9].
Quadruplex DNAs are known to inhibit telomerase [10^
13], HIV integrase [14] and thrombin [15,16]. Some of the
molecules that speci¢cally bind to quadruplex DNA are
cytotoxic to tumor cells presumably by means of telomer-
ase inhibition [10,12,13,17^20].
These and other biological results have kindled interest
in quadruplex DNA as therapeutics and as therapeutic
targets. The biological information is complemented by
the availability of structural information on quadruplex
DNAs [21^24] and by progress in understanding the na-
ture of the special interactions between quadruplex DNAs
and potassium [23,25,26].
The sections below give overviews of some of the pro-
posed roles of quadruplex DNA in replication, transcrip-
tion, and recombination and in the structures of triplet
repeat and telomere DNAs. The potential of quadruplex
DNA as targets for therapeutic intervention and as ther-
apeutics is also presented. As discussed below it appears
that the transient formation of quadruplex DNA can lead
to errors in transcription, replication, and recombination
while quadruplex DNA may play roles in recombination,
the formation of the synaptonemal complex, and in the
telomere structure of vertebrates. Before beginning the dis-
cussion of the biological roles of quadruplex DNAs the
diversity in the structural features of quadruplex DNAs
needs to be considered.
2. Quadruplex DNA structural types
Several types of quadruplex DNA structure, based on
quartets of dG residues, have been determined to high
resolution by solution state methods [21^24]. In a chair
or edge type structure the dG residues of each quartet
alternate syn^anti^syn^anti as depicted in Fig. 1. In the
crossover or basket type structure the dG residues alter-
nate syn^syn^anti^anti within each quartet as shown in
Fig. 1 and both intra- and intermolecular basket type
structures have been observed. The quadruplex structures
formed by four parallel strands [24,27,28] have all residues
anti as depicted in Fig. 1.
These three types of quadruplex structure have dis-
tinctly di¡erent shapes and electrostatic potentials [29^
31]. The chair type structures have two narrow grooves
and two wide grooves. The basket type structures have
one narrow, one wide and two medium width grooves.
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The parallel strand structures have all medium width
grooves. The electrostatic potentials of the narrow grooves
are quite strong and provide unique binding sites for cat-
ions and proteins [29^31]. Chair type structures appear to
have a requirement for potassium, or a suitable substitute
[23,25].
The terms ‘G4’, ‘tetraplex’ and ‘quadruplex’ have occa-
sionally been used to encompass this entire range of struc-
tures and on other occasions to describe a DNA sequence
whose quadruplex structural type was not known. Quad-
ruplex DNAs migrate faster in gels than do duplex DNAs
containing the same number of nucleotides and gel mobil-
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ity results have often been used as evidence for the pres-
ence of quadruplex DNA. There has not been a systematic
attempt to correlate the gel mobility with the struc-
tural types of quadruplex DNA. The N7 position of dG
residues in quartets is involved in Hoogsteen base pair-
ing, as shown in Fig. 1, which protects the site from chem-
ical modi¢cation. This feature allows chemical modi¢ca-
tion experiments to monitor the presence of quadruplex
DNA.
It appears that some of the discrepancies that appear in
the literature concerning the interactions, formation and
other properties of quadruplex DNA arise from the stud-
ies being on di¡erent structural types of quadruplex DNA.
Some DNA sequences can form more than one structure
as evidenced by the multiple bands that can be resolved by
gel electrophoresis. The mixture of structures can depend
on the concentration of the DNA and which cations are
present.
Investigations of the interactions and reactions of quad-
ruplex DNA should include results obtained with DNAs
of the known quadruplex structure. This can be done since
it is now known how to prepare DNAs of each of the
quadruplex structure types.
3. Replication and transcription
Bloom’s and Werner’s syndromes are caused by defects
in members of the RecQ family of ATP dependent heli-
cases [3^6,8,32]. Bloom’s syndrome is associated with a
wide range of symptoms that are linked to a very unstable
genome and to high rates of leukemia, solid tumors and
many other types of cancers [33,34]. Bloom’s syndrome is
caused by defects in the BLM gene that encodes a 1417
amino acid protein. Werner’s syndrome is associated with
an early onset of aging and with genetic instability [33,34].
Increased deletion of genes and the presence of chromo-
somal defects are associated with Werner’s syndrome. Un-
like Bloom’s syndrome, Werner’s syndrome does not ap-
pear to give rise to elevated levels of sister chromatid
exchange. Werner’s syndrome is caused by defects in the
WRN gene which encodes a 1432 amino acid protein. The
RecQ helicases unwind DNA in the 3P to 5P direction and
may have important interactions with topoisomerase III
[33] and polymerase N [35].
The yeast protein Sgs1 is also a member of the RecQ
family of ATP dependent helicases and defects in Sgs1 can
lead to errors in replication, transcription, high levels of
recombination and rapid aging [4,6,8]. The premature
aging caused by defects in Sgs1 can be compensated for
by BLM but not by WRN [36] while both WRN and
BLM can suppress the hyperrecombination caused by de-
fects in Sgs1 [37]. Yeast with temperature sensitive Sgs1
have drastically lowered DNA and RNA polymerase ac-
tivity at the restrictive temperature [8].
The BLM, WRN and Sgs1 RecQ helicases catalyze the
ATP dependent unwinding of quadruplex DNA and re-
quire the DNA to have a 3P tail of seven or more residues
[3^7]. A function of these RecQ helicases may be the res-
olution of quadruplex structures that appear during repli-
cation and transcription [3^5,9]. A model for this activity,
depicted in Fig. 2, predicts that DNA containing dG re-
peats can cause problems when defects in BLM or WRN
are present.
There are a couple of instances in which the presence of
quadruplex DNA may be needed to activate transcription.
The insulin mini-satellite of the insulin-linked polymorphic
region, a 14 bp long tandem repeat of d(ACAGGGG-
TGTGGGG), is located 363 nucleotides (nt) upstream of
the human insulin gene. Mutations that disrupt quadru-
plex structure formation by this mini-satellite disrupt in-
sulin gene transcription [38]. The presence of potassium
activates transcription and also exposes part of the control
region DNA to anti-gene silencing by anti-sense triplex
formation [39]. This potassium e¡ect supports the notion
that quadruplex structures are involved as the chair type
quadruplex structures require the presence of potassium
[23,25].
3.1. Questions and therapeutic potential
These results indicate that the transient formation of
quadruplex DNA can lead to errors in replication and
transcription. The errors can appear throughout the ge-
nome as there are many regions of DNA that have the
potential to form quadruplex DNA. One of the biological
Fig. 1. Four of the possible types of quadruplex structures based on quartets of dG residues are shown. In (A) the quadruplex structure is an intramo-
lecular basket type structure. On the left the structure is schematically depicted with the red boxes indicating the dG residues and the backbone of the
DNA shown in green. The structure is depicted in the middle and on the right the width of the grooves and the con¢guration of the residues in the dG
quartets. In (B) the quadruplex structure is an intermolecular basket type structure. On the left the structure is schematically depicted with the red
boxes indicating the dG residues of one strand and the orange boxes the dG residues of the other strand. The backbones of the DNAs are shown in
green. The structure is depicted in the middle and on the right the width of the grooves and the con¢guration of the residues in the dG quartets. In
(C) the quadruplex structure is an intramolecular chair type structure. On the left the structure is schematically depicted with the red boxes indicating
the dG residues and the backbone of the DNA shown in green. The structure is depicted in the middle and on the right the width of the grooves and
the con¢guration of the residues in the dG quartets. In (D) the quadruplex structure is a parallel strand type structure. On the left the structure is sche-
matically depicted with each color of box indicating the dG residues of one of the strands. The backbones of the DNAs are shown in green. The struc-
ture is depicted in the middle and on the right the width of the grooves and the con¢guration of the residues in the dG quartets. In (E) the orientation
of the base relative to the sugar is shown for syn and anti orientations.
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roles of the RecQ helicases may be to resolve such quad-
ruplex structures. Small molecule catalysis of the intercon-
version between quadruplex and single stranded DNA is a
route to therapeutic intervention when the quadruplex res-
olution activity is missing. Small molecules can catalyze
the interconversion between quadruplex structural types
[40,41] suggesting that small molecule based resolution
of quadruplex DNA may well be possible. Once the
DNA is converted to the single stranded form the proteins
which normally bind to single strand DNA may inhibit the
reformation of quadruplex DNA.
The kinetics, the number of ATP required and thermo-
dynamics of the resolution of quadruplex DNA by the
RecQ helicases need to be examined so as to assess
whether the activity actually occurs in cells and if so on
which of the types of quadruplex DNA. The WRN heli-
case, for example, can resolve quadruplex DNA formed
from repeats of d(CGG), associated with fragile X syn-
drome, but not those formed by the telomere repeat of
vertebrates, d(TTAGGG) [5]. Speci¢c inhibition of the res-
olution of quadruplex DNA by the RecQ helicases would
allow testing of the proposed model and a resolution assay
is needed to ¢nd inhibitors.
4. Recombination
During meiosis the sister chromatids pair up via the
formation of synaptonemal complexes which have shapes
that are characteristic for each species. These complexes
are formed via single strand cuts in the sister chromatids
followed by pairing of the homologous regions and then
by ligation of the invading strands of the two duplexes.
This leads to formation of a four strand, Holliday junction
which is subsequently resolved back into two duplexes by
the action of RecA helicase and other proteins. Many of
the proteins associated with recombination are also in-
volved in double strand DNA repair [42].
Single stranded DNA is transiently present during re-
combination which could allow the formation of quadru-
plex DNA when dG repeats are present [3,4]. The presence
of quadruplex DNA would cause errors in recombination.
This could lead to the formation of the quadriradial chro-
mosomes, that appear to be trapped in the middle of re-
combination, similar to the ones that are found in Bloom’s
syndrome cells [3].
Some of the proteins involved in synapsis are likely to
be expressed only during meiosis. About 10 years ago the
yeast meiosis speci¢c, 70 kDa protein Hop1, homology
promoter protein, was found [43]. Hop1 is essential for
the assembly of the synaptonemal complex [7,43]. Hop1
binds to quadruplex DNA with 0.2 nM a⁄nity and cata-
lyzes the formation of quadruplex DNA from single
stranded DNA [7]. These results have been taken to sug-
gest that quadruplex DNA may play a role in synapsis in
yeast [7]. Quadruplex DNA could form during recombi-
nation due to the transient presence of single stranded
DNA by a mechanism similar to that shown in Fig. 2.
Quadruplex DNA formed in association with Hop1 may
be needed for proper formation of some synaptonemal
complexes. It is noted that quadruplex DNA formation
is also catalyzed by various polycations [40] and it is not
known if Hop1 is acting other than as a non-speci¢c poly-
cation.
Duplex DNAs that have many consecutive dG^dG pairs
have been referred to as ‘synapsable’. Two such duplexes
Fig. 2. The process of replication is schematically depicted. The red
boxes indicate the positions of dG repeats in the leading strand and the
blue boxes the positions of the dG residues in the lagging strand. At
the replication fork there is single stranded DNA present which can al-
low quadruplex DNA to be formed as shown at the top of the ¢gure.
The quadruplex DNA could be formed with the strands being parallel
or anti-parallel as shown in the middle of the ¢gure. Once formed the
quadruplex DNA at the replication fork could act to halt replication.
The quadruplex structure could be resolved by the action of enzymes
such as the ATP dependent RecQ helicases. The structure shown at the
bottom contains a quadruplex DNA bridge between the two strands.
Such a structure could be formed from a quadruplex structure at the
replication fork. This structure could also be formed in recombination.
The single stranded DNA formed in recombination could combine with
the dG rich strand of the homologous DNA to form a quadruplex
bridge between the two duplexes.
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can join via quadruplex DNA structures involving the dG
residues on both strands of both duplexes [44]. We are not
aware of any situations in which a duplex DNA contain-
ing multiple consecutive dG^dG pairs occurs in vivo.
4.1. Questions
The potential role of quadruplex DNA in the synapto-
nemal complex is primarily based on the results obtained
on Hop1 and the model can be tested in several ways. One
approach to detecting the presence of quadruplex DNA in
synaptonemal complexes is to use one of the porphyrins
that become £uorescent only in the presence of quadruplex
DNA [40,45]. Another is to determine if one of the quad-
ruplex binding molecules disrupts synaptonemal forma-
tion. A third alternative is to compare the reconstitution
of the synaptonemal complex using native DNA with that
obtained using DNA in which a nucleotide that disrupts
quadruplex DNA formation has been incorporated. Nu-
cleotides such as 6-thioguaninosine or 7-deazaguanosine
disrupt quadruplex DNA formation [46^48].
5. Triplet repeat DNA
The molecular basis of at least a dozen human, genetic
based disorders is the expansion of the number of repeats
of a triplet sequence [49,50]. Triplet repeat diseases exhibit
non-Mendelian inheritance, as expansion can occur in a
single generation, and the genetic characteristic known as
anticipation. Anticipation refers to the tendency towards
earlier onset and increased severity as the number of re-
peats increases. The most studied case is fragile X syn-
drome which is associated with the d(CGG) repeat. The
fragile X repeat appears adjacent to the promoter region
of the FMR1, fragile X mental retardation-1, gene whose
product has an unknown function. Expansion of the num-
ber of repeats tends to suppress expression of FMR1 lead-
ing to the diseased state. The d(CGG) repeat occurs about
5^50 times in normal individuals, 40^230 times in carriers
and 230 to more than 2000 times in diseased individuals
[51].
There have been numerous studies of the properties of
DNA with the d(CGG)n repeats and the complementary
d(CCG)n [21,52]. Native gels of repeats of these DNA
indicate the presence of multiple forms that have been
proposed to have a number of di¡erent structural types
as reviewed elsewhere [50]. There is considerable evidence
that d(CGG)n repeats can form quadruplex DNA struc-
tures under physiological conditions. The formation of
quadruplex structures can lead to ‘slippage’ during repli-
cation, as depicted in Fig. 3, which can lead to expansion.
Similar quadruplex structures appear to be formed by all
d(NGG)n repeats [53]. WRN helicase can unwind quad-
ruplex structures formed by d(CGG)n repeats [5].
5.1. Questions and therapeutic potential
The formation of quadruplex DNA by triplet repeats
has been proposed to lead to errors in replication
[50,51,53]. This model remains to be rigorously tested. A
series of yeast, or other, cell lines that have various lengths
of d(CGG) repeats adjacent to the promoter of an easy to
characterize protein would seem to be a promising line of
inquiry. These cells could provide a good in vivo system
for testing both the quadruplex model as well as potential
therapeutics. The importance of quadruplex DNA in trip-
let expansion could be checked in such a model system by
the incorporation of nucleotides which disrupt quadruplex
DNA formation, such as 6-thioguaninosine or 7-deaza-
guanosine [46^48]. A potential route to therapeutic inter-
vention may be the use of small molecules to promote the
resolution of the quadruplex form.
It is not known whether the expansions of all triplet
repeats have a common mechanism. There is no compel-
ling reason as to why there should be a common mecha-
nism of triplet expansion. Some of the triplet repeats as-
sociated with disease states can not form quadruplex DNA
such as the d(AAG) repeat associated with Friederich’s
ataxia.
6. Telomere DNA and telomerase
One part of the ‘telomerase hypothesis’ is that telomer-
ase activity is needed for cells to divide inde¢nitely making
telomerase inhibition a prime chemotherapy target. An-
Fig. 3. During replication the formation of a quadruplex structure by
the leading strand can lead to the expansion of the DNA. Any stable
looped out form of DNA can lead to expansion.
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other part of the hypothesis is that the loss of telomerase
activity is a source of cellular aging and so turning telo-
merase on will allow cells to live longer. While therapy
based on telomerase inhibition appears promising
[17,19,54^59] the bene¢ts of telomerase activation are
less clear [60].
Telomerase is used to maintain the length of linear chro-
mosomes. This activity is needed since linear chromosomes
shorten each time the DNA is replicated. Tumor cells
divide inde¢nitely and about 85^90% of all tumor cells
examined to date have high levels of telomerase activity
[61^63] making telomerase a prime target for cancer ther-
apy [64^67]. Telomerase is inhibited by quadruplex DNA
[58,68]. The porphyrin T4 that speci¢cally binds to quad-
ruplex DNA [11,45,69] inhibits telomerase and is toxic to
tumor cells [10,12] making quadruplex DNA a promising
target for therapeutic intervention [20,58,59,70,71]. Addi-
tional molecules that bind to quadruplex DNA are also
known to inhibit telomerase [58].
While telomerase and HIV reverse transcriptase appear
to be closely related the nucleotide analogues e¡ective
against HIV reverse transcriptase do not necessarily have
activity against telomerase [59]. If the sole function of
telomerase was telomere maintenance then telomerase in-
hibition should not be toxic until several, or more, rounds
of replication. It has been shown that some telomerase
inhibitors can be toxic more quickly than this model sug-
gests and thus may act via mechanisms other than by
inhibiting telomere length maintenance by telomerase.
At one time telomere DNA was considered to be pri-
marily a protective cap to prevent chromosome fusion and
chromosome degradation. It is now becoming clear that
telomere DNA, and its associated proteins, adopt a unique
set of structures and play roles in cell cycle regulation,
cellular life span and gene silencing. Human telomere
DNA interacts with a large number of proteins including
RAP1, Ku, TRF1, TRF2, telomerase and others. Some of
these proteins only interact with telomere DNA, like
TRF1 and TRF2. Some, like RAP1 and Ku, also interact
with other DNA sequences. There is evidence that the
double strand break repair proteins may be required for
proper telomere maintenance.
Mammalian telomeres may form a loop as depicted in
Fig. 4 [72,73]. The proposed invasion of the duplex region
by the d(TTAGGG)n overhang is reminiscent of the junc-
tions present in recombination and replication. The joint
of the t-loop may involve the presence of quadruplex
structures and one such possibility is depicted in Fig. 4.
The structure of the DNA at the point of strand invasion
is not known at the present time. There are human nuclear
proteins that speci¢cally bind to d(CCCAAT) repeats and
these may be involved in stabilizing the complementary
strand when the d(TTAGGG)n strand forms quadruplex
structures [74]. The involvement of BLM in meiosis indi-
cates that quadruplex resolution of telomere DNA may be
important [37].
The telomere binding proteins of ciliates bind to the
d(GGGGTTTT)2 overhang found in the mini-chromo-
somes of the macronucleus [72]. Quadruplex DNA is not
found in the complexes between the telomere binding pro-
tein and d(GGGGTTTT)2 [72]. These results are not di-
rectly related to what occurs in mammalian telomeres as
the overhang is shorter, the proteins are di¡erent and there
is no t-loop in the macronucleus of ciliates amongst other
di¡erences. The DNA in the ciliate micronucleus appears
to form a t-loop like that found in mammalian cells [72].
6.1. Questions and therapeutic potential
The limited data that is currently available indicates
that molecules that bind to quadruplex DNA can inhibit
telomerase. A working model is that the binding stabilizes
the quadruplex form of the DNA and the stabilized com-
plex inhibits telomerase both in vitro and in vivo. Only a
small number of molecules that bind to quadruplex DNA
have been investigated and relatively little is known about
the ones that have been found. Given the unique structur-
al features of each of the types of quadruplex DNA, it
should be possible to ¢nd drug-like molecules that bind
to each type of quadruplex DNA with nanomolar, or
Fig. 4. In mammalian chromosomes the d(TTAGGG)n repeat may fold
back and invade the duplex region to form a t-loop. There is typically
3000^20 000 nt of telomere DNA and the overhang is typically 130^270
nt in length. The size of the t-loop depends on the length of the telo-
mere DNA and if there are not enough repeats of the telomere DNA or
if the overhang is too short then the t-loop may not form. A possible
structure for the t-loop is shown.
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higher, a⁄nity. The availability of such molecules will al-
low testing of the hypothesis that quadruplex DNA is a
good target for chemotherapeutic intervention and which
type of quadruplex DNA should be targeted. Some inhib-
itors that target quadruplex DNA may also inhibit the
activity of RecQ helicases, Hop1 and other proteins giving
rise to signi¢cant side e¡ects.
For a joint, as depicted in Fig. 4, to occur repeats of
d(TTAGGG) need to form quadruplex structures. The
quadruplex structures formed by d(TTAGGG)n contain
crucial information in deciphering how molecules that
bind to quadruplex DNA inhibit telomerase as well as in
guiding the design of better inhibitors. Methods for the
detection of quadruplex DNA in mixtures are needed to
determine the presence of quadruplex DNA in the struc-
tures formed by telomere DNA free and in association
with proteins.
The quadruplex structures that can be formed by telo-
mere DNA are not well characterized. There is compelling
evidence that d(TTAGGG)4 forms a quadruplex structure,
at least in the presence of potassium, but the structure is
yet to be determined [46,48]. Results obtained by nucleo-
tide substitution on the gel mobility of d(TTAGGG)4
are not entirely consistent [46,48]. The thermal stability
of the quadruplex form of d(TTAGGG)4 observed in gel
experiments is much higher than that of the sequence
used in a nuclear magnetic resonance based structural
study.
It is also noted that while quadruplex DNA is an inhib-
itor of telomerase, so are 7-deazaguanosine [75] and 6-
thioguaninosine [76]. Neither of these modi¢ed guanines
can participate in quadruplex DNA formation [46^48].
Taken together the results suggest that quadruplex DNA
is needed at one step since these nucleotide analogs block
quadruplex structure formation while quadruplex DNA
can inhibit additional steps of telomerase activity. It may
be the case that these two steps involve di¡erent structural
types of quadruplex DNA.
7. Quadruplex DNAs as therapeutics
Directed evolution is based on the mimicry of biological
processes for the discovery of potential therapeutic agents
[77,78] and can now be carried out in conjunction with
high throughput screening. A successful application of a
directed evolution methodology has been the discovery
of a class of DNA molecules that bind to and inhibit
thrombin [15]. An aptamer is an RNA or DNA molecule
that binds to a speci¢c molecular target. The sequence
d(GGTTGGTGTGGTTGG) was the DNA aptamer
with the highest a⁄nity for thrombin in the original
screens [15]. This DNA aptamer signi¢cantly increases
the thrombin catalyzed clotting times of both puri¢ed ¢-
brinogen and human plasma and does not compete with
known active site inhibitors of thrombin [15]. This DNA
adopts an intramolecular chair type quadruplex structure
containing dG quartets, as depicted in Fig. 1, and the
tertiary structure determines the activity of the aptamer
[16,30]. The structural information has been used to guide
the development of more e¡ective inhibitors of thrombin
[79].
DNAs with sequences consistent with the formation of
quadruplex structures have been found to be potent inhib-
itors of HIV-1 integrase [14]. Potassium appears to pri-
marily e¡ect the structure of the loops of the quadruplex
structures formed by those DNAs that inhibit integrase
[14].
8. Other interactions of quadruplex DNAs
The nuclear protein LR1 is B-cell type speci¢c and binds
to quadruplex DNA with nanomolar a⁄nity [1]. LR1 is
thought to play a key role in immunoglobin switch recom-
bination [1]. Nucleolin, an abundant protein in the nucle-
olus, binds to quadruplex DNA with about 1 nM a⁄nity
[1,2]. Nucleolin may be involved in rDNA processing,
transcription, replication and recombination [2]. Rat livers
express two hnRNP proteins which bind to telomere DNA
with nanomolar a⁄nity that can unwind quadruplexes
formed from fragile X repeat DNA but not those formed
from telomere or immunoglobin repeats [9,80]. A protein
with quadruplex DNA resolvase activity has been puri¢ed
from human placenta [81].
9. Future directions
This survey indicates that quadruplex DNA may be in-
volved in a number of biological systems. However, many
of the studies have used DNAs that may form multiple
structures making it di⁄cult to ascertain which quadru-
plex structure type, or types, were involved in the interac-
tions examined. The use of DNAs that form a known,
single quadruplex structure will allow the interactions to
be better characterized and may also indicate that the
binding a⁄nities are stronger than those deduced from
results on the DNAs that adopt multiple structures. To
further characterize the resolution activity of the RecQ
helicases, and other proteins, the catalysis of the formation
of quadruplex DNA by Hop1 assays needs to be devel-
oped for studying the kinetics and equilibria between sin-
gle stranded, duplex and quadruplex forms of DNA. Such
assays may also allow the development of small molecules
that catalyze the resolution of quadruplex DNA as well as
inhibitors of the RecQ helicases.
A few molecules have been found which selectively bind
to quadruplex DNA. These molecules have o¡ered the
opportunity to begin the examination of the e¡ects of
targeting quadruplex DNA both in vitro and in vivo. Giv-
en the di¡erences between the structural types of quadru-
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plex DNA it should be possible to speci¢cally target each
of the quadruplex types.
Many systems of interest, like triplet repeat DNAs, ap-
pear to form a wide range of structures. Thus, methods
are needed which allow the characterization of the struc-
tures present and their sensitivity to environmental condi-
tions. This could be accomplished by the combined use of
native gels and staining with molecules that speci¢cally
bind to quadruplex DNA. More detailed information
could be obtained by the use of molecules that speci¢cally
stain a single quadruplex structural type.
As molecules that speci¢cally bind to quadruplex DNA
have been found, and even more speci¢c and tighter bind-
ers are sure to be found, it should be possible to speci¢-
cally target each type of quadruplex DNA for reaction
and possibly subsets of each structural type. Reactive
groups can be added to the quadruplex speci¢c binders
to speci¢cally cleave quadruplex DNA both in vivo and
in vitro to obtain targeted quadruplex speci¢c nuclease
activity.
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